Acciones Bausch Health Companies Inc Toronto S.E.
Acciones
CA91911K1021
Farmacéuticos
Ventas 2024 * | 9385,77 M 12,83 mil M 8778,14 M | Ventas 2025 * | 9453,31 M 12,92 mil M 8841,31 M | Capitalización | 3193,72 M 4365,5 M 2986,96 M |
---|---|---|---|---|---|
Resultado Neto 2024 * | 336 M 459 M 314 M | Resultado Neto 2025 * | 381 M 521 M 356 M | VE / Ventas 2024 * | 2,46 x |
Deuda neta 2024 * | 19,91 mil M 27,21 mil M 18,62 mil M | Deuda neta 2025 * | 18,33 mil M 25,05 mil M 17,14 mil M | VE / Ventas 2025 * | 2,28 x |
P/E ratio 2024 * |
13,2
x | P/E ratio 2025 * |
8,46
x | Empleados | - |
Rendimiento 2024 * |
-
| Rendimiento 2025 * |
-
| Flotante | 97,66 % |
Último transcript sobre Bausch Health Companies Inc
Directores | Puesto | Edad | Desde |
---|---|---|---|
Thomas Appio
CEO | Chief Executive Officer | 61 | - |
John Barresi
DFI | Director of Finance/CFO | 51 | 24/05/22 |
Chief Operating Officer | - | - |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Robert Power
BRD | Director/Board Member | 67 | 01/08/08 |
John Paulson
CHM | Chairman | 68 | 01/06/17 |
Steven Miller
BRD | Director/Board Member | 35 | 17/03/21 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+25,83 % | 661 mil M | |
+27,00 % | 566 mil M | |
-6,76 % | 352 mil M | |
+20,34 % | 332 mil M | |
+3,00 % | 283 mil M | |
+13,09 % | 231 mil M | |
+5,46 % | 200 mil M | |
-9,61 % | 195 mil M | |
-6,26 % | 145 mil M |